FreeCME

Improving Long-Term Outcomes in Schizophrenia: The Role of Long-Acting Injectables Web Activity

Jointly sponsored by Postgraduate Institute for Medicine, Global Medical Education and HealthmattersCME.

This activity is supported in part by an independent education grant from ABC.

Specialty: Psychiatric Medicine

Release date: January 27, 2014

Valid through: January 27, 2015

Target Audience:

Program Overview:

The Webcast Improving Long-Term Outcomes in Schizophrenia: The Role of Long-Acting Injectables will begin with a discussion on the clinical and economic challenges that mediation non adherence poses for the patient with schizophrenia and the health care system that supports that patient. It will then provide a state-of-the-art review of the clinical data on the current long-acting pharmacologic interventions to improve medication adherence and review the safety, efficacy and adverse events profiles of agents in order to assist clinicians in making informed choices.

Credit Types

1.25 AMA PRA Category 1™ Credit Hours

1.2 Nursing Contact Hours

All other healthcare professionals completing this course will be issued a statement of participation.